San Francisco, June 17 : Tesla and SpaceX CEO Elon Musk has said that his brain-computer interface company Neuralink is likely to begin the first human trial this year.

Last month, Neuralink received US Food and Drug Administration (FDA) approval to begin its first-in-human clinical study, which means that actual humans could have a Neuralink device implanted in their heads.

"We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study," Neuralink said.